Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.09
-0.08-6.84%
Last update: Oct 2, 7:38 PM
$1.07
-0.1-8.55%
NuCana PLC (NCNA) Stock Price, Quote, News & History
NCNANASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of NuCana (NASDAQ:NCNA) through any online brokerage.
Other companies in NuCana’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
NuCana has a consensus price target of $5000.00.
The stock price for NuCana (NASDAQ: NCNA) is $1.07 last updated October 2, 2026 at 7:38 PM EDT.
There are no upcoming dividends for NuCana.
NuCana does not have any upcoming earnings scheduled.
There is no upcoming split for NuCana.
NuCana is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
